Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Lai

Showing results (101-110 of 209) with videos related to

Pageof 21
Sort By:
Cancers|May 28, 2022
Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective StudyJingwen Yao, Akifumi Hagiwara, Talia C Oughourlian, et al.
Radiology Case Reports|March 2, 2026
A multifocal IDH-mutant glioma with differential response to IDH inhibition: Role of quantitative neuroimagingOmar Ibrahim, Nicholas S Cho, Viên Lam Le, et al.
Neuro-Oncology|April 22, 2026
Modeling Gliomas with Organoids: Classification, Fidelity, and Guidelines for Translational Neuro-OncologyChristopher G Hubert, Renee D Read, Tyler E Miller, et al.
Journal of Neuro-Oncology|April 22, 2018
<sup>18</sup>F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional studyChirag B Patel, Elisa Fazzari, Ararat Chakhoyan, et al.
Neuro-Oncology Advances|August 9, 2023
Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastomaSonoko Oshima, Akifumi Hagiwara, Catalina Raymond, et al.
Npj Metabolic Health and Disease|July 3, 2025
Publisher Correction: Valproic acid targets IDH1 mutants through alteration of lipid metabolismLubayna S Elahi, Michael C Condro, Riki Kawaguchi, et al.
Npj Metabolic Health and Disease|August 16, 2024
Valproic acid targets IDH1 mutants through alteration of lipid metabolismLubayna S Elahi, Michael C Condro, Riki Kawaguchi, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Plos One|September 7, 2012
K-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivoIrmgard Hofmann, Andreas Weiss, Gaelle Elain, et al.
Neuro-Oncology Advances|April 7, 2022
Prognostic value of <i>O</i> <sup>6</sup>-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomasKeng Lam, Blaine S C Eldred, Bryan Kevan, et al.
Pageof 21

Showing results (101-110 of 209) with videos related to

Sort By:
Pageof 21
Cancers|May 28, 2022
Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective StudyJingwen Yao, Akifumi Hagiwara, Talia C Oughourlian, et al.
Radiology Case Reports|March 2, 2026
A multifocal IDH-mutant glioma with differential response to IDH inhibition: Role of quantitative neuroimagingOmar Ibrahim, Nicholas S Cho, Viên Lam Le, et al.
Neuro-Oncology|April 22, 2026
Modeling Gliomas with Organoids: Classification, Fidelity, and Guidelines for Translational Neuro-OncologyChristopher G Hubert, Renee D Read, Tyler E Miller, et al.
Journal of Neuro-Oncology|April 22, 2018
<sup>18</sup>F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional studyChirag B Patel, Elisa Fazzari, Ararat Chakhoyan, et al.
Neuro-Oncology Advances|August 9, 2023
Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastomaSonoko Oshima, Akifumi Hagiwara, Catalina Raymond, et al.
Npj Metabolic Health and Disease|July 3, 2025
Publisher Correction: Valproic acid targets IDH1 mutants through alteration of lipid metabolismLubayna S Elahi, Michael C Condro, Riki Kawaguchi, et al.
Npj Metabolic Health and Disease|August 16, 2024
Valproic acid targets IDH1 mutants through alteration of lipid metabolismLubayna S Elahi, Michael C Condro, Riki Kawaguchi, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Plos One|September 7, 2012
K-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivoIrmgard Hofmann, Andreas Weiss, Gaelle Elain, et al.
Neuro-Oncology Advances|April 7, 2022
Prognostic value of <i>O</i> <sup>6</sup>-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomasKeng Lam, Blaine S C Eldred, Bryan Kevan, et al.
Pageof 21